Intellectual Property - October 21, 2025
Alligator Bioscience granted US patent
The United States Patent and Trademark Office has granted a patent covering the composition of matter of ATOR-4066, the company’s bispecific antibody targeting CD40 and CEACAM5.
Collaboration - October 21, 2025
A Nordic model for pandemic preparedness
A new Nordic research network develops models that can estimate how an infection will spread, thereby supporting rapid response during a future pandemic.
Collaboration - October 20, 2025
Lundbeck and Contera Pharma enter research collaboration
The two companies have announced a strategic research collaboration aiming to accelerate the discovery and development of innovative oligonucleotide-based medicines for patients living with serious neurological conditions.
Clinical Trials - October 20, 2025
Aqilion announces new clinical pharmacokinetic study results
The company has announced positive results from the ARIA-2 clinical study.
Biotech Business - October 20, 2025
Xbrane provides disappointing regulatory update on FDA review
The FDA has issued a Complete Response Letter (CRL) to the company’s Biologics License Application (BLA) for its ranibizumab biosimilar candidate for treatment of retinal disorders.
Pharma Business - October 16, 2025
Novo Nordisk and Omeros enter purchase and license agreement
The companies have entered into a definitive asset purchase and license agreement for the candidate drug zaltenibart (formerly OMS906) in clinical development for rare blood and kidney disorders.
